RecruitingNot ApplicableNCT06449937

Local Liver Treatment for Multi-organ Colorectal Cancer Metastases

Analysis of the Efficacy of Local Liver Treatment for Multi-organ Colorectal Cancer Metastases: A Prospective, Multicenter, Non-randomized Concurrent Controlled Study


Sponsor

Anhui Provincial Hospital

Enrollment

130 participants

Start Date

Jul 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study was to investigate the effect of only local radical treatment of liver metastases combined with systematic treatment in the treatment of patients with multiple organ metastases of colorectal cancer, whether it can benefit the prognosis and explore the risk factors related to the prognosis.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study investigates whether adding local liver treatment (such as ablation or embolization) to systemic chemotherapy improves survival in patients with colorectal cancer that has spread to both the liver and other organs. **You may be eligible if...** - You are between 18 and 80 years old - You have colorectal cancer with confirmed spread to both the liver and at least one other site (such as lungs or lymph nodes) - Your primary colorectal tumor has been or can be surgically removed - You are receiving first- or second-line chemotherapy **You may NOT be eligible if...** - Your extrahepatic (outside the liver) metastases are not stable or controllable - You have received more than two lines of chemotherapy Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURERadical local Surgery

Radical local resection of liver metastases ( hepatectomy, ablation )

DRUGSystemic therapy

Chemotherapy, targeted drug therapy, immunotherapy treatment.

OTHERInterventional therapy

Transcatheter arterial chemoembolization (TACE) Hepatic arterial infusion chemotherapy (HAIC)


Locations(6)

The First People's Hospital of Chu Zhou

Chuzhou, Anhui, China

Fuyang Cancer Hospital

Fuyang, Anhui, China

Anhui province hospital

Hefei, Anhui, China

Ma'anshan People's Hospital

Ma’anshan, Anhui, China

The First Affiliated Hospital of Wannan Medical College

Wuhu, Anhui, China

The Second People's Hospital of Wuhu

Wuhu, Anhui, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06449937


Related Trials